Xencor (XNCR) Asset Writedowns and Impairment (2013 - 2025)

Xencor (XNCR) reported Asset Writedowns and Impairment of -$8.3 million for Q4 2025, down 629.58% quarter-over-quarter from $1.6 million in Q3 2025.

Xencor (XNCR) Asset Writedowns and Impairment (2013 - 2025) Analysis & Trends

Xencor (XNCR) has 13 years of Asset Writedowns and Impairment data on file, last reported at -$8.3 million in Q4 2025.

  • Asset Writedowns and Impairment for Q4 2025 came in at -$8.3 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was -$4.9 million (down 204.74% YoY), and the FY2024 annual result was $20.4 million, up 1512.47% from the prior year.
  • Asset Writedowns and Impairment retreated to -$8.3 million in Q4 2025 per XNCR's latest filing, from $1.6 million in the prior quarter.
  • Over five years, Asset Writedowns and Impairment peaked at $20.6 million in Q1 2024 and troughed at -$8.3 million in Q4 2025.
  • A 5-year average of $1.4 million and a median of $300000.0 in 2022 frame the typical range for Asset Writedowns and Impairment.
  • On a YoY basis, Asset Writedowns and Impairment climbed as much as 6333.02% in 2024 and fell as far as 173.33% in 2024.
  • A 5-year view of Asset Writedowns and Impairment shows it stood at $207000.0 in 2021, then slipped by 13.53% to $179000.0 in 2022, then soared by 162.57% to $470000.0 in 2023, then tumbled by 146.81% to -$220000.0 in 2024, then slumped by 3667.27% to -$8.3 million in 2025.
  • Business Quant data shows XNCR's Asset Writedowns and Impairment at -$8.3 million in Q4 2025, $1.6 million in Q3 2025, and $1.9 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Xencor 953.38 Mn 878.64 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 -8.29 Mn
Dec 31, 2025 -8.29 Mn
Sep 30, 2025 1.57 Mn
Sep 30, 2025 1.57 Mn
Jun 30, 2025 1.86 Mn
Jun 30, 2025 1.86 Mn
Mar 31, 2025 4.87 Mn
Mar 31, 2025 4.87 Mn
Jun 30, 2024 -220,000.00
Jun 30, 2024 -220,000.00
Mar 31, 2024 20.65 Mn
Mar 31, 2024 20.65 Mn
Dec 31, 2023 470,000.00
Dec 31, 2023 470,000.00
Sep 30, 2023 200,000.00
Sep 30, 2023 200,000.00
Jun 30, 2023 300,000.00
Jun 30, 2023 300,000.00
Mar 31, 2023 321,000.00
Mar 31, 2023 321,000.00